Citation: | Shen T,Zhu F.Research progress of mucormycosis in burns[J].Chin J Burns Wounds,2023,39(12):1195-1200.DOI: 10.3760/cma.j.cn501225-20231101-00165. |
[1] |
SoboutiB, DahmardeheiM, FallahS, et al. Candidemia in pediatric burn patients: risk factors and outcomes in a retrospective cohort study[J]. Curr Med Mycol, 2020, 6(3):33-41. DOI: 10.18502/cmm.6.3.4663.
|
[2] |
DangJ, GoelP, ChoiKJ, et al. Mucormycosis following burn injuries: a systematic review[J]. Burns, 2023,49(1):15-25. DOI: 10.1016/j.burns.2022.05.012.
|
[3] |
FréalleE, RocchiS, BacusM, et al. Real-time polymerase chain reaction detection of Lichtheimia species in bandages associated with cutaneous mucormycosis in burn patients[J]. J Hosp Infect, 2018,99(1):68-74. DOI: 10.1016/j.jhin.2018.02.004.
|
[4] |
FarmerAR, MurrayCK, DriscollIR, et al. Combat-related pythium aphanidermatum invasive wound infection: case report and discussion of utility of molecular diagnostics[J]. J Clin Microbiol, 2015,53(6):1968-1975. DOI: 10.1128/JCM.00410-15.
|
[5] |
HospenthalDR, ChungKK, LairetK, et al. Saksenaea erythrospora infection following combat trauma[J]. J Clin Microbiol, 2011,49(10):3707-3709. DOI: 10.1128/JCM.05095-11.
|
[6] |
DevauchelleP, JeanneM, FréalleE. Mucormycosis in burn patients[J]. J Fungi (Basel), 2019, 5(25):1-12.DOI: 10.3390/jof5010025.
|
[7] |
JeongW, KeighleyC, WolfeR, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports[J]. Clin Microbiol Infect, 2019,25(1):26-34. DOI: 10.1016/j.cmi.2018.07.011.
|
[8] |
LittlehalesE, TeagueR, AndrewD, et al. Mucormycosis in burns: a review[J]. J Burn Care Res, 2022,43(2):353-360. DOI: 10.1093/jbcr/irab236.
|
[9] |
MitchellTA, HardinMO, MurrayCK, et al. Mucormycosis attributed mortality: a seven-year review of surgical and medical management[J]. Burns, 2014,40(8):1689-1695. DOI: 10.1016/j.burns.2014.03.013.
|
[10] |
RibeiroNF, HeathCH, KierathJ, et al. Burn wounds infected by contaminated water: case reports, review of the literature and recommendations for treatment[J]. Burns, 2010,36(1):9-22. DOI: 10.1016/j.burns.2009.03.002.
|
[11] |
ChristiaensG, HayetteMP, JacqueminD, et al. An outbreak of Absidia corymbifera infection associated with bandage contamination in a burns unit[J]. J Hosp Infect, 2005,61(1):88. DOI: 10.1016/j.jhin.2004.12.011.
|
[12] |
BakerRD. Pulmonary mucormycosis[J]. Am J Pathol,1956,32(2):287-313.
|
[13] |
FoleyFD, ShuckJM3rd, FishbeinMC, et al. Burn-wound infection with phycomycetes requiring amputation of hand[J]. JAMA, 1968, 203(8):596. DOI: 10.1001/jama.1968.03140080056017.
|
[14] |
Garcia-HermosoD, CriscuoloA, LeeSC, et al. Outbreak of invasive wound mucormycosis in a burn unit due to multiple strains of Mucor circinelloides f. circinelloides resolved by whole-genome sequencing[J]. mBio, 2018, 9(2):e00573-18. DOI: 10.1128/mBio.00573-18.
|
[15] |
SchaalJV, LeclercT, SolerC, et al. Epidemiology of filamentous fungal infections in burned patients: a French retrospective study[J]. Burns, 2015,41(4):853-863. DOI: 10.1016/j.burns.2014.10.024.
|
[16] |
ReidG, LynchJP, FishbeinMC, et al. Mucormycosis[J]. Semin Respir Crit Care Med, 2020,41(1):99-114. DOI: 10.1055/s-0039-3401992.
|
[17] |
SatiH, BeardsleyJ, Alastruey-IzquierdoA, et al. WHO fungal priority pathogens list to guide research development and public health[M]. Geneva: World Health Organization,2022. DOI: 10.13140/RG.2.2.31126.63040.
|
[18] |
李峰,杨红明,王宏伟.烧伤患者毛霉菌侵袭性感染(附4例报告)并文献复习[J/CD].中华损伤与修复杂志(电子版), 2011, 6(3):3.DOI: 10.3877/cma.j.issn.1673-9450.2011.03.012.
|
[19] |
SteinbrinkJM, MiceliMH. Mucormycosis[J]. Infect Dis Clin North Am, 2021,35(2):435-452. DOI: 10.1016/j.idc.2021.03.009.
|
[20] |
CornelyOA, Alastruey-IzquierdoA, ArenzD, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium[J]. Lancet Infect Dis, 2019,19(12):e405-e421. DOI: 10.1016/S1473-3099(19)30312-3.
|
[21] |
VenkateshD, DandagiS, ChandrappaPR, et al. Mucormycosis in immunocompetent patient resulting in extensive maxillary sequestration[J]. J Oral Maxillofac Pathol, 2018,22(Suppl 1):S112-116. DOI: 10.4103/jomfp.JOMFP_163_17.
|
[22] |
SkiadaA, Lass-FloerlC, KlimkoN, et al. Challenges in the diagnosis and treatment of mucormycosis[J]. Med Mycol, 2018,56(Suppl_1):S93-101. DOI: 10.1093/mmy/myx101.
|
[23] |
ChermetzM, GobboM, RupelK, et al. Combined orofacial aspergillosis and mucormycosis: fatal complication of a recurrent paediatric glioma-case report and review of literature[J]. Mycopathologia, 2016, 181(9/10):723-733. DOI: 10.1007/s11046-016-0021-8.
|
[24] |
DhaliwalHS, SinghA, SinhaSK, et al. Diagnosed only if considered: isolated renal mucormycosis[J]. Lancet, 2015,385(9984):2322. DOI: 10.1016/S0140-6736(15)60730-9.
|
[25] |
KungVL, ChernockRD, BurnhamCD. Diagnostic accuracy of fungal identification in histopathology and cytopathology specimens[J]. Eur J Clin Microbiol Infect Dis, 2018,37(1):157-165. DOI: 10.1007/s10096-017-3116-3.
|
[26] |
MiceliMH, MaertensJ. Role of non-culture-based tests, with an emphasis on galactomannan testing for the diagnosis of invasive aspergillosis[J]. Semin Respir Crit Care Med, 2015, 36(5):650-661. DOI: 10.1055/s-0035-1562892.
|
[27] |
DonnellyJP, ChenSC, KauffmanCA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium[J]. Clin Infect Dis, 2020, 71(6):1367-1376. DOI: 10.1093/cid/ciz1008.
|
[28] |
ChamilosG, MaromEM, LewisRE, et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer[J]. Clin Infect Dis, 2005,41(1):60-66. DOI: 10.1086/430710.
|
[29] |
HammerMM, MadanR, HatabuH. Pulmonary mucormycosis: radiologic features at presentation and over time[J]. AJR Am J Roentgenol, 2018, 210(4):742-747. DOI: 10.2214/AJR.17.18792.
|
[30] |
JungJ, KimMY, LeeHJ, et al. Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis[J]. Clin Microbiol Infect, 2015,21(7):684.e11-e18. DOI: 10.1016/j.cmi.2015.03.019.
|
[31] |
IbrahimAS, SpellbergB, WalshTJ, et al. Pathogenesis of mucormycosis[J]. Clin Infect Dis, 2012,54(Suppl 1):S16-22. DOI: 10.1093/cid/cir865.
|
[32] |
AkersKS, RowanMP, NieceKL, et al. Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report[J]. BMC Infect Dis, 2015,15:184. DOI: 10.1186/s12879-015-0918-8.
|
[33] |
LedgardJP, van HalS, GreenwoodJE. Primary cutaneous zygomycosis in a burns patient: a review[J]. J Burn Care Res, 2008,29(2):286-290. DOI: 10.1097/BCR.0b013e31816673b1.
|
[34] |
RodriguezCJ, TribbleDR, MaloneDL, et al. Treatment of suspected invasive fungal infection in war wounds[J]. Mil Med, 2018,183(Suppl_2):S142-146. DOI: 10.1093/milmed/usy079.
|
[35] |
WarkentienT, RodriguezC, LloydB, et al. Invasive mold infections following combat-related injuries[J]. Clin Infect Dis, 2012,55(11):1441-1449. DOI: 10.1093/cid/cis749.
|
[36] |
KontoyiannisDP, LewisRE. How I treat mucormycosis[J]. Blood, 2011,118(5):1216-1224. DOI: 10.1182/blood-2011-03-316430.
|
[37] |
MariaNC, PimjaiN. Deferiprone as adjunctive treatment for patients with invasive mucormycosis: a retrospective case series[J]. Infectious Disease Reports, 2018,10(2):7765. DOI: 10.4081/idr.2018.7765.
|